what is glp 1 and gip receptor agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Polyagonists Enable Increasingly Effective Treatment
Description
Both work well
& Muskiet, M
Persistent whole day meal effects of three dipeptidyl peptidase-4 inhibitors on glycaemia and hormonal responses in metformin-treated type 2 diabetes
Uncontrolled hypothyroidism should be addressed first, as inadequate thyroid hormone replacement can contribute to weight gain and may complicate the assessment of Wegovy's effectiveness
(Gross spending does not account for rebates that result in lower net spending.) Ozempic (semaglutide injection) was approved in December 2017
